Aromasin (Exemestane)

Aromasin represents a more advanced class of estrogen management, known as a Type I steroidal suicide inhibitor. Unlike Arimidex, which simply binds to the aromatase enzyme, Aromasin forms a permanent, covalent bond that effectively kills the enzyme.

This means there is no possibility of an estrogen rebound when the medication is stopped, as the body must manufacture entirely new enzymes to begin the aromatization process again. This biological finality makes Aromasin a favorite for those ending a cycle or transitioning into post cycle therapy. One of the most significant advantages of Aromasin is its impact on other hormones; it has been shown to lower Sex Hormone Binding Globulin (SHBG) and potentially increase IGF-1 levels. By lowering SHBG, Aromasin increases the percentage of free testosterone in the blood.

Pharmacologically, Aromasin is fat soluble, and its bioavailability increases by roughly 40% when taken with a meal containing fats. If taken on an empty stomach, it is significantly less effective. Because it is a steroidal compound, it is often reported to be more forgiving on the cardiovascular system and cholesterol profiles than other inhibitors, provided estrogen is not crashed. However, the suicide nature of the drug means that if you do take too much and crash your estrogen, you are essentially stuck in that low estrogen state for several weeks until your body can regenerate the destroyed enzymes. This can lead to a long period of depressed mood, flat muscles, and joint pain. Most users titrate their dose carefully, often starting at 12.5mg every three days, and only increasing if symptoms of high estrogen, like itchy nipples or extreme bloat persist.